These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38572627)

  • 1. Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone.
    Grob F; Keshwani R; Angley E; Zacharin M
    J Paediatr Child Health; 2024; 60(2-3):53-57. PubMed ID: 38572627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
    Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism.
    Boeri L; Capogrosso P; Salonia A
    Curr Pharm Des; 2021; 27(24):2775-2783. PubMed ID: 32445446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puberty induction with recombinant gonadotropin: What impact on future fertility?
    Lambert AS; Bouvattier C
    Ann Endocrinol (Paris); 2022 Jun; 83(3):159-163. PubMed ID: 35436503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations Among Genotype and Outcome in Chinese Male Patients With Congenital Hypogonadotropic Hypogonadism Under HCG Treatment.
    Chen Y; Sun T; Niu Y; Wang D; Xiong Z; Li C; Liu K; Qiu Y; Sun Y; Gong J; Wang T; Wang S; Xu H; Liu J
    J Sex Med; 2020 Apr; 17(4):645-657. PubMed ID: 32171629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis.
    Alexander EC; Faruqi D; Farquhar R; Unadkat A; Ng Yin K; Hoskyns R; Varughese R; Howard SR
    Eur J Endocrinol; 2024 Jan; 190(1):S1-S11. PubMed ID: 38128110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal control of spermatogenesis in men: therapeutic aspects in hypogonadotropic hypogonadism.
    Pitteloud N; Dwyer A
    Ann Endocrinol (Paris); 2014 May; 75(2):98-100. PubMed ID: 24793994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Puberty induction in boys with congenital isolated hypogonadotropic hypogonadism].
    Kokoreva KD; Chugunov IS; Kareva MA; Bezlepkina OB
    Probl Endokrinol (Mosk); 2023 Feb; 69(1):59-67. PubMed ID: 36842078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults.
    Rohayem J; Sinthofen N; Nieschlag E; Kliesch S; Zitzmann M
    Andrology; 2016 Jan; 4(1):87-94. PubMed ID: 26779870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Combined Low Dose Human Gonadotropic Hormone, Follicle Stimulating Hormone, and Testosterone Therapy (LFT Regimen) Versus Conventional High Dose Human Gonadotropic Hormone and Follicle Stimulating Hormone on Spermatogenesis and Biomarkers in Men With Hypogonadotropic Hypogonadism.
    Singhania N; Devi KB; Kaur J; Bhansali A; Gorsi U; Sachdeva N; Arora S; Rai A; Walia R
    Endocr Pract; 2024 Oct; 30(10):978-986. PubMed ID: 39025301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of reproductive and non-reproductive outcomes of gonadotropin mediated pubertal induction in male patients with congenital hypogonadotropic hypogonadism (CHH).
    Cangiano B; Goggi G; Federici S; Bresesti C; Cotellessa L; Guizzardi F; Vezzoli V; Duminuco P; Persani L; Bonomi M
    J Endocrinol Invest; 2021 Nov; 44(11):2445-2454. PubMed ID: 33738751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.
    Delemarre-van de Waal HA
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U89-94. PubMed ID: 15554892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome.
    Raivio T; Wikström AM; Dunkel L
    Eur J Endocrinol; 2007 Jan; 156(1):105-11. PubMed ID: 17218732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism.
    Barrio R; de Luis D; Alonso M; Lamas A; Moreno JC
    Fertil Steril; 1999 Feb; 71(2):244-8. PubMed ID: 9988392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
    Zacharin M; Sabin MA; Nair VV; Dabadghao P
    Fertil Steril; 2012 Oct; 98(4):836-42. PubMed ID: 22763096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
    Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G
    Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
    Trabado S; Maione L; Bry-Gauillard H; Affres H; Salenave S; Sarfati J; Bouvattier C; Delemer B; Chanson P; Le Bouc Y; Brailly-Tabard S; Young J
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E268-75. PubMed ID: 24243640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study.
    Chen YW; Niu YH; Xu H; Wang DQ; Jiang HY; Pokhrel G; Wang T; Wang SG; Liu JH
    Asian J Androl; 2019; 21(4):413-418. PubMed ID: 30604694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients.
    Hao M; Nie M; Yu BQ; Gao YJ; Wang X; Ma WL; Huang QB; Zhang R; Mao JF; Wu XY
    Asian J Androl; 2020; 22(4):390-395. PubMed ID: 31464203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
    Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
    Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.